Oxitropium
- Level
- Commodity
- Parent
- 51393700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51393701This classification denotes an antimuscarinic agent with the molecular structure C19H26NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 8G15T83E6I chemically known as (7(s)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.))-9-ethyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane but generally known as oxitropium, which bears US NIH Compound Identifier 5311335. European Medicines Agency schedules Oxitropium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03574MIG. As of Q4 2014, OXITROPIUM remains the US FDA Preferred Term for this commodity. Oxitropium bears US NLM identifiers UMLS ID C0069776 and NCI Concept Code C87641. SMILES: BR.O1C2C3[N](C(C12)CC(OC(=O)C(CO)C1CCCCC1)C3)(CC)C.
Same parent
Under 51393700 · 4Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.